1998
DOI: 10.1016/s0887-8994(97)00153-7
|View full text |Cite
|
Sign up to set email alerts
|

Clinical efficacy of piracetam in treatment of breath-holding spells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
17
0
4

Year Published

2002
2002
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(24 citation statements)
references
References 15 publications
3
17
0
4
Order By: Relevance
“…The significant decline in the number of attacks/month after administration of piracetam was marked in the first and second months, and it was less pronounced in the third and fourth months when compared with the first and second months. Our results are in agreement with many authors who found that piracetam is an effective drug in the treatment and prophylaxis of BHS [3,7].…”
Section: Discussionsupporting
confidence: 94%
See 1 more Smart Citation
“…The significant decline in the number of attacks/month after administration of piracetam was marked in the first and second months, and it was less pronounced in the third and fourth months when compared with the first and second months. Our results are in agreement with many authors who found that piracetam is an effective drug in the treatment and prophylaxis of BHS [3,7].…”
Section: Discussionsupporting
confidence: 94%
“…Donma found that incidence of side effects of piracetam was not different from that of placebo [7]. Winnicka et al reported that piracetam generally has minimal or no side effects.…”
Section: Discussionmentioning
confidence: 99%
“…It is imperative to rule out other causes of loss of consciousness and seizures in breath-holders. Multiple medications have been tried with variable success, including iron therapy for children with low hemoglobin levels (18), piracetam (19), and central sympathetic modulators such as tetrabenzamine and clonidine for cyanotic BHS (12). Because bradycardia and asystole, especially in pallid BHS, are most likely mediated by excessive parasympathetic tone, anticholinergic treatment with atropine (20) or transdermal scopolamine (21) has been attempted with inconsistent results.…”
Section: Figure 1) a Rhythm Strip From An Event Recorder At The Time mentioning
confidence: 99%
“…In een ander onderzoek (een RCT) werden 76 kinderen ingesloten. 12 Het betrof zowel patiënten met cyanotische BHS als bleke BHS. Hiervan kregen 39 kinderen piracetam (40 mg/kg/dagelijks gedurende 2 maanden); de andere 37 kinderen kregen een placebo.…”
Section: Etiologie En Klinisch Beeldunclassified